7Baggers
 Avoiding Lag: Real-Time Signals in (PRTA) Movement  news.stocktradersdaily.com Sat, 08 Nov 2025 08:14:02 GMT
 prothena tightens losses and focuses on its drug pipeline  Finimize Sat, 08 Nov 2025 06:45:32 GMT
 prothena corp (prta) receives updated buy rating from hc wainwri  GuruFocus Sat, 08 Nov 2025 06:26:04 GMT
 prothena corp (prta) receives updated buy rating from hc wainwri  GuruFocus Fri, 07 Nov 2025 20:43:26 GMT
 Prothena Corp (PRTA) Analyst Ratings: RBC Capital's New Price Ta  GuruFocus Fri, 07 Nov 2025 20:19:16 GMT
 Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 Prothena Tightens Losses And Focuses On Its Drug Pipeline  Finimize Fri, 07 Nov 2025 07:20:50 GMT
 prothena corporation’s q3 2025 financial and clinical updates  TipRanks Fri, 07 Nov 2025 05:25:01 GMT
 Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates  sharewise.com Fri, 07 Nov 2025 00:33:49 GMT
 prothena reports q3 eps (68c), consensus (54c)  TipRanks Thu, 06 Nov 2025 23:57:54 GMT
 Prothena earnings beat by $0.04, revenue fell short of estimates  Investing.com Thu, 06 Nov 2025 22:43:05 GMT
 Prothena Corp PLC Reports Q3 2025 EPS of -$0.68, Revenue Falls S  GuruFocus Thu, 06 Nov 2025 22:00:09 GMT
 Prothena Q3 net loss narrows to $36.5 mln  TradingView Thu, 06 Nov 2025 21:58:53 GMT
 Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Prothena Corporation’s Q3 2025 Financial and Clinical Updates  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Prothena: Q3 Earnings Snapshot  New Haven Register Thu, 06 Nov 2025 08:00:00 GMT
 prothena (prta) to release quarterly earnings on thursday  MarketBeat Sun, 02 Nov 2025 12:44:16 GMT
 Prothena to Report Third Quarter 2025 Financial Results on November 6  Business Wire Thu, 30 Oct 2025 07:00:00 GMT
 prothena (nasdaq:prta) shares gap up on analyst upgrade  MarketBeat Wed, 29 Oct 2025 14:54:18 GMT
 prothena stock price target raised to $36 from $15 at piper sandler by investing.com  Investing.com South Africa Wed, 29 Oct 2025 07:49:15 GMT

Prothena Corporation plc
(NASDAQ:PRTA) 

PRTA stock logo

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other relate...

Founded: 2012
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends